Jpmorgan Chase & Co »

Seelos Therapeutics Ord shares owned by Jpmorgan Chase & Co

Quarter-by-quarter ownership of Seelos Therapeutics Ord (SEEL) shares owned by Jpmorgan Chase & Co from 13F filings

Historical chart of Jpmorgan Chase & Co investment in Seelos Therapeutics Ord

Tip: Access up to 7 years of quarterly data

All positions including Seelos Therapeutics Ord held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Seelos Therapeutics Ord by Jpmorgan Chase & Co

Quarter filed Position value Share count Share price at filing
2023-12-31 $2.8k 2.0k 1.39

More positions owned by Jpmorgan Chase & Co

Microsoft Corp Common (MSFT)
Apple Common (AAPL)
Amazon Common (AMZN)
Spdr S&p 500 Etf Trust Fund (SPY)
Nvidia Corporation Common (NVDA)
Meta Platforms Common (META)
Unitedhealth Group Common (UNH)
Vanguard Total Intl Bond Etf Fund (BNDX)
Alphabet Common (GOOG)
Eli Lilly & Co Common (LLY)
Mastercard Incorporated Common (MA)
Alphabet Common (GOOGL)
Abbvie Common (ABBV)
Vanguard Total Bond Market Fund (BND)
Tesla Common (TSLA)

View all positions for Jpmorgan Chase & Co

Top funds holding Seelos Therapeutics Ord

Wealth Effects
Vanguard Group
Balyasny Asset Management
Jeffrey L. Gendell
Modera Wealth Management
Citadel Advisors
Lynwood Capital Management
Strategic Family Wealth Counselors
Two Sigma Investments
CRA Financial Services
Wealth Enhancement Advisory Services
Advisor Group Holdings
Carmichael Hill & Associates
Bank of America Corporation
Jpmorgan Chase & Co

View all funds holding Seelos Therapeutics Ord